Peripheral T_reg Levels and Transforming Growth Factor-β (TGFβ) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis

[1]  Mengyao Wang,et al.  The Role of Helper T Cells in Psoriasis , 2021, Frontiers in Immunology.

[2]  Bryar T Ahmed,et al.  TGF-β1 Gene Polymorphism and Its Correlation with Serum Level of TGF-β1 in Psoriasis Vulgaris Among Iraqi People , 2020, Clinical, cosmetic and investigational dermatology.

[3]  L. Coates,et al.  Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire , 2020, Health and Quality of Life Outcomes.

[4]  Jing Luo,et al.  The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2 , 2020, Therapeutic advances in chronic disease.

[5]  Xiaofeng Li,et al.  The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis , 2019, Journal of immunology research.

[6]  C. Scheinecker,et al.  Treg cells in autoimmunity: from identification to Treg-based therapies , 2019, Seminars in Immunopathology.

[7]  Chong Gao,et al.  The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis. , 2019, Multiple sclerosis and related disorders.

[8]  J. Luo,et al.  Increased CD4+CD25-Foxp3+ T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement , 2018, Lupus.

[9]  I. Kamp-Becker,et al.  Meta-meta-analysis on the effectiveness of parent-based interventions for the treatment of child externalizing behavior problems , 2018, PloS one.

[10]  Xiaofeng Li,et al.  The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis , 2018, Journal of immunology research.

[11]  R. M. de Souza,et al.  Analysis of the lymphocyte cell population during malaria caused by Plasmodium vivax and its correlation with parasitaemia and thrombocytopaenia , 2018, Malaria Journal.

[12]  Wei Tang,et al.  Role of PIM2 in allergic asthma , 2017, Molecular medicine reports.

[13]  D. Veale,et al.  Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors , 2015, Annals of the rheumatic diseases.

[14]  G. Basso,et al.  Transcriptional network profile on synovial fluid T cells in psoriatic arthritis , 2015, Clinical Rheumatology.

[15]  R. D. Hatton,et al.  IL-1 signaling modulates STAT activation to antagonize retinoic acid signaling and control Th17–iTreg balance , 2015, Nature Immunology.

[16]  G. Basso,et al.  JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis , 2014, Immunologic Research.

[17]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[18]  Yong Guo,et al.  The expression and significance of CD4+CD25+CD127low/- regulatory T cells and Foxp3 in patients with portal hypertension and hypersplenism. , 2013, Hepato-Gastroenterology.

[19]  W. Lai,et al.  [Expression of Th17/Treg cell in patients with psoriasis arthritis and its clinical significance]. , 2012, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[20]  S. Ishihara,et al.  The Role of IL-15 in Activating STAT5 and Fine-Tuning IL-17A Production in CD4 T Lymphocytes , 2012, The Journal of Immunology.

[21]  Xiangpei Li,et al.  CD4+CD25+CD127low/− T Cells: A More Specific Treg Population in Human Peripheral Blood , 2012, Inflammation.

[22]  Grégoire Altan-Bonnet,et al.  Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses , 2012, Front. Immun..

[23]  Andreas Radbruch,et al.  Synovial and Peripheral Blood CD4+FoxP3+ T Cells in Spondyloarthritis , 2011, The Journal of Rheumatology.

[24]  Riitta Lahesmaa,et al.  Genomic views of STAT function in CD4+ T helper cell differentiation , 2011, Nature Reviews Immunology.

[25]  J. O’Shea,et al.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 , 2011, Nature Immunology.

[26]  M. Day,et al.  Immunomodulatory drugs and their application to the management of canine immune-mediated disease. , 2011, The Journal of small animal practice.

[27]  S. Sakaguchi.  Regulatory T cells: history and perspective. , 2011, Methods in molecular biology.

[28]  E. Martı́n-Mola,et al.  A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4+CD25+ Regulatory T Cells and CD4+CD25− Responder T Cells1 , 2009, The Journal of Immunology.

[29]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[30]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[31]  D. Speiser,et al.  Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. , 2008, Arthritis and rheumatism.

[32]  M. Battaglia,et al.  STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. , 2008, International immunology.

[33]  D. Ebo,et al.  Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis. , 2008, Cellular immunology.

[34]  A. Hinks,et al.  SNPs in the FOXP3 gene region show no association with Juvenile Idiopathic Arthritis in a UK Caucasian population. , 2007, Rheumatology.

[35]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[36]  N. Munshi,et al.  Dysfunctional T regulatory cells in multiple myeloma. , 2006, Blood.

[37]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[38]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[39]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[40]  S. Sakaguchi,et al.  Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation , 1996, The Journal of experimental medicine.

[41]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[42]  A. Rubins,et al.  Subpopulations of T lymphocytes in psoriasis patients and their changes during immunotherapy. , 1987, Journal of the American Academy of Dermatology.

[43]  E. Keystone,et al.  Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. , 1982, Clinical and experimental immunology.